These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36046692)

  • 21. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
    Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R
    Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of inward rectifier potassium current ionic channel remodeling by AT
    He J; Xu Y; Yang L; Xia G; Deng N; Yang Y; Tian Y; Fu Z; Huang Y
    Cell Biol Int; 2018 Sep; 42(9):1149-1159. PubMed ID: 29719087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
    Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
    Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin/NFAT and Smad-7.
    Li X; Chu G; Zhu F; Zheng Z; Wang X; Zhang G; Wang F
    Exp Cell Res; 2020 Jan; 386(1):111716. PubMed ID: 31734152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sanggenon C protects against pressure overload‑induced cardiac hypertrophy via the calcineurin/NFAT2 pathway.
    Xiao L; Gu Y; Gao L; Shangguan J; Chen Y; Zhang Y; Li L
    Mol Med Rep; 2017 Oct; 16(4):5338-5346. PubMed ID: 28849031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling.
    Pushpakumar SB; Kundu S; Metreveli N; Sen U
    PLoS One; 2013; 8(12):e83813. PubMed ID: 24386282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy.
    Zhao Q; Song W; Huang J; Wang D; Xu C
    Curr Res Transl Med; 2021 Jan; 69(1):103270. PubMed ID: 33268288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells.
    Liu CJ; Cheng YC; Lee KW; Hsu HH; Chu CH; Tsai FJ; Tsai CH; Chu CY; Liu JY; Kuo WW; Huang CY
    Mol Cell Biochem; 2008 Jun; 313(1-2):167-78. PubMed ID: 18398669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
    Sugiyama A; Okada M; Yamawaki H
    Eur J Pharmacol; 2020 Mar; 871():172849. PubMed ID: 31843516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Na(+)/H(+) exchanger 1 directly binds to calcineurin A and activates downstream NFAT signaling, leading to cardiomyocyte hypertrophy.
    Hisamitsu T; Nakamura TY; Wakabayashi S
    Mol Cell Biol; 2012 Aug; 32(16):3265-80. PubMed ID: 22688515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low doses of folic acid can reduce hyperhomocysteinemia-induced glomerular injury in spontaneously hypertensive rats.
    Gao N; Zhang Y; Lei L; Li L; Cao P; Zhao X; Lin L; Xu R
    Hypertens Res; 2020 Nov; 43(11):1182-1191. PubMed ID: 32439914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation.
    Rajapurohitam V; Izaddoustdar F; Martinez-Abundis E; Karmazyn M
    Cell Signal; 2012 Dec; 24(12):2283-90. PubMed ID: 22917533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.
    Bao Y; Li R; Jiang J; Cai B; Gao J; Le K; Zhang F; Chen S; Liu P
    Mol Cell Biochem; 2008 Oct; 317(1-2):189-96. PubMed ID: 18600431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
    MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
    Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes.
    Kesherwani V; Nandi SS; Sharawat SK; Shahshahan HR; Mishra PK
    Mol Cell Biochem; 2015 Jun; 404(1-2):241-50. PubMed ID: 25763715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of calcineurin in angiotensin II-induced cardiac myocyte hypertrophy of rats.
    Fu M; Zhang J; Xu S; Pang Y; Liu N; Tang C
    Chin Med Sci J; 2001 Mar; 16(1):1-4. PubMed ID: 12899339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.
    Bian ZY; Huang H; Jiang H; Shen DF; Yan L; Zhu LH; Wang L; Cao F; Liu C; Tang QZ; Li H
    Hypertension; 2010 Feb; 55(2):257-63. PubMed ID: 20026769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy.
    Bernt A; Rangrez AY; Eden M; Jungmann A; Katz S; Rohr C; Müller OJ; Katus HA; Sossalla ST; Williams T; Ritter O; Frank D; Frey N
    Sci Rep; 2016 Oct; 6():35758. PubMed ID: 27767176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.